Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma
Conclusions: Combined application of HA/CPPs-10-HCPT-NPs and LIFU should be a valuable and promising strategy for precise HCC theranostics.
Source: Theranostics - Category: Molecular Biology Authors: Hongyun Zhao, Meng Wu, Leilei Zhu, Yi Tian, Mingxing Wu, Yizhen Li, Liming Deng, Wei Jiang, Wei Shen, Zhigang Wang, Zhechuan Mei, Pan Li, Haitao Ran, Zhiyi Zhou, Jianli Ren Tags: Research Paper Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Men | Nanotechnology | PET Scan | Ultrasound | Urology & Nephrology